
Release date: 2026-03-30 17:45:47 Article From: Lucius Laos Recommended: 10
As a targeted therapy, ivosidenib may cause certain side effects while exerting its anti-tumor effects.
Common side effects include cracked lips, decreased appetite, diarrhea, difficulty swallowing, nausea, and vomiting.
Black, tarry stools; bleeding gums; blood in the urine or stool; blurred vision; burning, tingling, numbness, or pain in the hands, arms, feet, or legs; chest pain or tightness; chills; confusion; cough; decreased urine output; difficulty or labored breathing; difficulty moving; dizziness, fainting, or lightheadedness when rising suddenly from a lying or sitting position; eye pain; fainting; fever; general feeling of discomfort; headache; arrhythmia (recurrent); joint pain, stiffness, or swelling; lower back, flank, or abdominal pain; muscle pain, cramps, soreness, or stiffness; painful or difficult urination; pale skin; pinpoint red spots on the skin; rapid weight gain; rash; tingling sensation; sore throat; sores, ulcers, or white spots on the lips, tongue, or inside the mouth; stabbing pain; swelling of the arms, feet, or lower legs; unusual bleeding or bruising; unusual tiredness or weakness.
Inability to move the arms and legs; sudden numbness and weakness in the arms and legs.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:2002025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:4332024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:2082025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:2232025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:1982025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:2292025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:2152025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:1962025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: